Literature DB >> 19322161

Bullous pemphigoid: a prototypical antibody-mediated organ-specific autoimmune disease.

Cassian Sitaru1.   

Abstract

Bullous pemphigoid (BP) is a prototypical organ-specific autoimmune disease. Autoantibodies unfold their blister-inducing potential by triggering an Fcgamma-dependent inflammatory reaction. The study by Iwata et al. in this issue provides the first direct evidence that IgG autoantibodies from BP patients may also weaken cell-matrix adhesion by depleting BP180/type XVII collagen from cultured keratinocytes. These novel findings shed new light on additional mechanisms of blister formation in pemphigoid diseases and open the way for further informative studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19322161     DOI: 10.1038/jid.2009.12

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

1.  Cross-reactivity of autoantibodies from patients with epidermolysis bullosa acquisita with murine collagen VII.

Authors:  Kinga Csorba; Alina Sesarman; Eva Oswald; Vasile Feldrihan; Anja Fritsch; Takashi Hashimoto; Cassian Sitaru
Journal:  Cell Mol Life Sci       Date:  2010-01-20       Impact factor: 9.261

2.  Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseases.

Authors:  Kinga Csorba; Sabine Schmidt; Florina Florea; Norito Ishii; Takashi Hashimoto; Michael Hertl; Sarolta Kárpáti; Leena Bruckner-Tuderman; Wataru Nishie; Cassian Sitaru
Journal:  Orphanet J Rare Dis       Date:  2011-05-28       Impact factor: 4.123

3.  The flavonoid luteolin inhibits Fcγ-dependent respiratory burst in granulocytes, but not skin blistering in a new model of pemphigoid in adult mice.

Authors:  Eva Oswald; Alina Sesarman; Claus-Werner Franzke; Ute Wölfle; Leena Bruckner-Tuderman; Thilo Jakob; Stefan F Martin; Cassian Sitaru
Journal:  PLoS One       Date:  2012-02-06       Impact factor: 3.240

4.  Complement-Activating Capacity of Autoantibodies Correlates With Disease Activity in Bullous Pemphigoid Patients.

Authors:  Roxana M Chiorean; Adrian Baican; Mayson B Mustafa; Annette Lischka; Daniel-Corneliu Leucuta; Vasile Feldrihan; Michael Hertl; Cassian Sitaru
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

Review 5.  Deciphering the Contribution of BP230 Autoantibodies in Bullous Pemphigoid.

Authors:  Connor Cole; Luca Borradori; Kyle T Amber
Journal:  Antibodies (Basel)       Date:  2022-06-28

6.  Follicular helper T Cells (Tfh) and IL-21 involvement in the pathogenesis of bullous pemphigoid.

Authors:  Qiuju Li; Zhenfeng Liu; Erle Dang; Liang Jin; Zheng He; Luting Yang; Xiaowei Shi; Gang Wang
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

Review 7.  Molecular diagnosis in autoimmune skin blistering conditions.

Authors:  J V Otten; T Hashimoto; M Hertl; A S Payne; C Sitaru
Journal:  Curr Mol Med       Date:  2014-01       Impact factor: 2.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.